摘要
当前核医学产业不断发展,国产核医学品牌市场占有率也在逐年提高,但我国在核医学领域与发达国家仍存在较大差距。文章旨在探索核医学产业链中的投资机会和投资风险管理以及实施成功的投资策略,以给投资者提供在该领域进行决策的参考。通过综合文献综述和实证研究,文章分析了核医学产业链的发展趋势、市场规模以及相关技术和政策因素。通过综合考虑这些因素,投资者可以制定针对核医学产业链的投资策略,降低风险并实现可持续的投资回报。
At present,the nuclear medicine industry continues to develop,and the market share of domestic nuclear medicine brands is also increasing year by year,but there is still a big gap between our country and developed countries in the nuclear medicine field.This study aims to explore investment opportunities and investment risk management in the nuclear medicine industry chain and the implementation of successful investment strategies to provide investors with a reference for decisionmaking in this field.Through the comprehensive literature review and empirical research,this study analyzes the development trend,market size,and related technology and policy factors.By taking these factors into account,investors can develop investment strategies for the nuclear medicine industry chain t o reduce risks and achieve sustainable investment returns.
作者
宗高旭
ZONG Gaoxu(HTA Co.,Ltd.,Beijing 102445,China)
出处
《商业观察》
2023年第36期41-44,共4页
BUSINESS OBSERVATION
关键词
核医学产业链
投资策略
发展
nuclear medicine industry chain
investment strategy
developm ent